2BB score and signals
NRX Pharmaceuticals, Inc.’s current 2BB score is 18 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 6 | Very Low |
| Momentum | 31 | Weakening |
| Financial strength | 12 | Very Weak |
| Quality | 60 | Strong |
| Risk | 64 | High |
Company facts
| Headquarters | Wilmington, Delaware, United States |
| Founded | 2015 |
| Employees | 29 |
| 52-week range | $1.62 – $5.06 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-16 | — | 0.0592 | — | $17.84M |
| 2026-08-17 | — | 0.0653 | — | $16.89M |
| 2026-05-15 | -0.04 | 0.2932 | $1.07M | $26.08M |
| 2026-03-23 | -0.012 | -0.0026 | $983,000.00 | $7.68M |
Related companies
2BBBullish & Bearish